Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Matthews Andrea | Chief Business Officer | 7 | $0 | $0 | 2026-01-23 |
| Morabito Christopher | Chief Medical Officer | 15 | $0 | $247.3K | 2026-01-23 |
| Callori Fred | Director | 10 | $0 | $0 | 2026-01-23 |
| Clauser Noah | Chief Financial Officer | 6 | $0 | $0 | 2026-01-23 |
| Komjathy Andrew | Chief Commercial Officer | 10 | $670 | $0 | 2026-01-23 |
| Beck Joanne T. | Director | 10 | $0 | $0 | 2026-01-23 |
| Violin Jonathan | Director | 13 | $0 | $0 | 2026-01-23 |
| Harshbarger Benjamin | Chief Legal Officer | 7 | $0 | $0 | 2026-01-23 |
| Milne Jill C. | CEO and President | 7 | $0 | $0 | 2026-01-23 |
| AGARWAL SUNIL | Director | 4 | $0 | $0 | 2026-01-23 |
| Cole Hugh M | Director | 10 | $0 | $0 | 2026-01-23 |
| LAPOINTE ANTHONY GREGG | Director | 10 | $0 | $0 | 2026-01-23 |
| BATE KENNETH | Director | 10 | $0 | $0 | 2026-01-23 |
| KISHBAUCH MICHAEL D | Director | 10 | $0 | $0 | 2026-01-23 |
| Perceptive Xontogeny Venture Fund, LP | Director | 1 | $30.00M | $0 | 2024-02-01 |
| PERCEPTIVE ADVISORS LLC | Director | 1 | $4.59M | $0 | 2023-12-21 |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | 7 | $35.98M | $0 | 2023-10-16 |
| Nichols Andrew John | Chief Scientific Officer | 1 | $0 | $0 | 2022-03-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| AGARWAL SUNIL | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 28,200 | — | $0 | 0 | SEC↗ |
| AGARWAL SUNIL | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| BATE KENNETH | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| BATE KENNETH | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| BATE KENNETH | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| BATE KENNETH | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| BATE KENNETH | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| Beck Joanne T. | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Beck Joanne T. | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Beck Joanne T. | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| Beck Joanne T. | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| Beck Joanne T. | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,166 | — | $0 | 0 | SEC↗ |
| Clauser Noah | Chief Financial Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 55,000 | — | $0 | 0 | SEC↗ |
| Clauser Noah | Chief Financial Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 262,500 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| Harshbarger Benjamin | Chief Legal Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 55,000 | — | $0 | 0 | SEC↗ |
| Harshbarger Benjamin | Chief Legal Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 262,500 | — | $0 | 0 | SEC↗ |
| Harshbarger Benjamin | Chief Legal Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 33,333 | — | $0 | 0 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 55,000 | — | $0 | 0 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 225,000 | — | $0 | 0 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Matthews Andrea | Chief Business Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 32,812 | — | $0 | 0 | SEC↗ |
| Matthews Andrea | Chief Business Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Matthews Andrea | Chief Business Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 262,500 | — | $0 | 0 | SEC↗ |
| Milne Jill C. | CEO and President | D To issuer deriv | 2026-01-23 | 2026-01-23 | 195,000 | — | $0 | 0 | SEC↗ |
| Milne Jill C. | CEO and President | D To issuer deriv | 2026-01-23 | 2026-01-23 | 761,000 | — | $0 | 0 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 80,000 | — | $0 | 0 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | D To issuer deriv | 2026-01-23 | 2026-01-23 | 262,500 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,166 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | Director | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | D To issuer | 2026-01-23 | 2026-01-23 | 45 | — | $0 | 0 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | D To issuer | 2026-01-23 | 2026-01-23 | 45 | — | $0 | 0 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | D To issuer | 2026-01-23 | 2026-01-23 | 10 | — | $0 | 0 | SEC↗ |
| Milne Jill C. | CEO and President | D To issuer | 2026-01-23 | 2026-01-23 | 4,377 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | Director | D To issuer | 2026-01-23 | 2026-01-23 | 263,321 | — | $0 | 0 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| Beck Joanne T. | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| Cole Hugh M | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | A Award deriv | 2025-03-21 | 2025-03-25 | 262,500 | — | $0 | 262,500 | SEC↗ |
| Clauser Noah | Chief Financial Officer | A Award deriv | 2025-03-21 | 2025-03-25 | 262,500 | — | $0 | 262,500 | SEC↗ |
| Harshbarger Benjamin | Chief Legal Officer | A Award deriv | 2025-03-21 | 2025-03-25 | 262,500 | — | $0 | 262,500 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | A Award deriv | 2025-03-21 | 2025-03-25 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Matthews Andrea | Chief Business Officer | A Award deriv | 2025-03-21 | 2025-03-25 | 262,500 | — | $0 | 262,500 | SEC↗ |
| Milne Jill C. | CEO and President | A Award deriv | 2025-03-21 | 2025-03-25 | 761,000 | — | $0 | 761,000 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Cole Hugh M | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Beck Joanne T. | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2024-04-08 | 2024-04-09 | 28,200 | — | $0 | 28,200 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | M Exercise deriv | 2024-04-01 | 2024-04-03 | 10,000 | — | $0 | 80,000 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | S Sale | 2024-04-01 | 2024-04-03 | 10,000 | $13.59 | $135.9K | 0 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | M Exercise | 2024-04-01 | 2024-04-03 | 10,000 | $3.87 | $38.7K | 10,000 | SEC↗ |
| Clauser Noah | Chief Financial Officer | A Award deriv | 2024-02-08 | 2024-02-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Harshbarger Benjamin | Chief Legal Officer | A Award deriv | 2024-02-08 | 2024-02-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | A Award deriv | 2024-02-08 | 2024-02-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Matthews Andrea | Chief Business Officer | A Award deriv | 2024-02-08 | 2024-02-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Milne Jill C. | CEO and President | A Award deriv | 2024-02-08 | 2024-02-12 | 534,600 | — | $0 | 534,600 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | A Award deriv | 2024-02-08 | 2024-02-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Perceptive Xontogeny Venture F | Director | P Buy | 2024-02-01 | 2024-02-05 | 2,481,350 | $12.09 | $30.00M | 4,873,721 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | M Exercise deriv | 2024-01-29 | 2024-01-30 | 9,200 | — | $0 | 90,000 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | M Exercise | 2024-01-29 | 2024-01-30 | 9,200 | $3.87 | $35.6K | 9,200 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | S Sale | 2024-01-29 | 2024-01-30 | 9,200 | $11.15 | $102.6K | 0 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | M Exercise deriv | 2024-01-26 | 2024-01-30 | 800 | — | $0 | 99,200 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | S Sale | 2024-01-26 | 2024-01-30 | 800 | $11.02 | $8.8K | 0 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | M Exercise | 2024-01-26 | 2024-01-30 | 800 | $3.87 | $3.1K | 800 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | Director | P Buy | 2023-12-21 | 2023-12-22 | 740,000 | $6.20 | $4.59M | 2,392,371 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | Director | P Buy deriv | 2023-10-16 | 2023-10-18 | 614,062 | $6.51 | $4.00M | 460,546 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | Director | P Buy deriv | 2023-10-16 | 2023-10-18 | 921,093 | $6.51 | $6.00M | 1,151,366 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | Director | P Buy deriv | 2023-10-16 | 2023-10-18 | 921,093 | $6.51 | $6.00M | 921,093 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | Director | P Buy deriv | 2023-10-16 | 2023-10-18 | 460,546 | $6.51 | $3.00M | 345,409 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | Director | P Buy | 2023-10-16 | 2023-10-18 | 460,546 | $6.51 | $3.00M | 1,611,699 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | Director | P Buy | 2023-10-16 | 2023-10-18 | 614,062 | $6.51 | $4.00M | 1,652,371 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Beck Joanne T. | Director | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Clauser Noah | Chief Financial Officer | A Award deriv | 2023-06-02 | 2023-06-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | A Award deriv | 2023-06-02 | 2023-06-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Cole Hugh M | Director | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| Harshbarger Benjamin | Chief Legal Officer | A Award deriv | 2023-06-02 | 2023-06-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | A Award deriv | 2023-06-02 | 2023-06-06 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Matthews Andrea | Chief Business Officer | A Award deriv | 2023-06-02 | 2023-06-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Milne Jill C. | CEO and President | A Award deriv | 2023-06-02 | 2023-06-06 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Matthews Andrea | Chief Business Officer | A Award deriv | 2023-04-17 | 2023-04-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | Director | P Buy | 2022-12-19 | 2022-12-21 | 908,265 | $11.01 | $10.00M | 1,038,309 | SEC↗ |
| Morabito Christopher | Chief Medical Officer | A Award deriv | 2022-08-01 | 2022-08-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Cole Hugh M | Director | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Beck Joanne T. | Director | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Callori Fred | Director | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Cole Hugh M | Director | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Beck Joanne T. | Director | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| BATE KENNETH | Director | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Nichols Andrew John | Chief Scientific Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Milne Jill C. | CEO and President | A Award deriv | 2022-03-01 | 2022-03-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Clauser Noah | Chief Financial Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Harshbarger Benjamin | Chief Legal Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Komjathy Andrew | Chief Commercial Officer | P Buy | 2021-11-19 | 2021-11-23 | 100 | $6.70 | $670 | 100 | SEC↗ |
| Violin Jonathan | Director | J Other | 2021-09-20 | 2021-09-22 | 263,321 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | Director | J Other | 2021-09-20 | 2021-09-22 | 263,321 | — | $0 | 263,321 | SEC↗ |